Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2 | Q05397 | 2/20 | 0.47 |
| ▸ | HTR7 | P34969 | 3/20 | 0.44 |
| ▸ | UTS2R | Q9UKP6 | 11/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6826209 | 0.90 | PTK2 (0.46) | PTK2HTR7UTS2RMEN1ALDH1A1 | |
| SCHEMBL6820571 | 0.88 | PTK2 (0.49) | PTK2HTR7UTS2RHTR1A | |
| SCHEMBL6824127 | 0.84 | HTR7 (0.45) | PTK2HTR7UTS2RHTR1AACHE | |
| SCHEMBL6823920 | 0.83 | PTK2 (0.45) | PTK2HTR7UTS2RMEN1KMT2A | |
| SCHEMBL6826210 | 0.80 | PTK2 (0.44) | PTK2HTR7UTS2RHTR1A | |
| SCHEMBL6824418 | 0.74 | HTR7 (0.40) | PTK2HTR7UTS2RMEN1KMT2A | |
| SCHEMBL6824544 | 0.72 | HTR7 (0.40) | PTK2HTR7UTS2RMEN1KMT2A | |
| SCHEMBL6381981 | 0.72 | HTR7 (0.49) | HTR7UTS2RHTR1A | |
| SCHEMBL6823956 | 0.72 | HTR7 (0.47) | HTR7UTS2RMEN1KMT2AHTR1A | |
| SCHEMBL6820544 | 0.71 | UTS2R (0.38) | PTK2HTR7UTS2RMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004076444-A2 | NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-10 | — | — | WO | claimed |
| WO-2004076444-A2 | NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-10 | — | — | WO | disclosed |